ibex Q4 FY26 slides: AI push drives growth, margins face pressure

ibex reported Q4 FY2026 revenue of $164.3 million and adjusted EPS of $0.85, beating consensus estimates of $153.38 million and $0.79, respectively, as organic revenue rose 12% year over year. However, adjusted EBITDA margin compressed 160bps to 12.3%, and FY2027 revenue guidance of $700-$715 million implies slower 9%-11% growth versus 15% organic growth in FY2026. Shares fell 2.0% after hours to $36.51 as investors prioritized margin pressure and decelerating growth despite early traction from AI customer-service deployments.

Analysis

The central underwriting question is whether AI deployments are additive to IBEX’s revenue base or simply accelerate deflation in its labor-hour pricing. High containment rates initially support implementation, integration and outcome-based fees, but sustained automation reduces the addressable agent-seat pool unless IBEX captures a meaningful share of software economics. Sierra therefore creates both a differentiation vector versus legacy CX outsourcers such as TTEC and Concentrix (CNXC) and a dependency risk: AI vendors could eventually sell directly to enterprise customers or route work to lower-cost operators.

The next 1-3 months should be driven less by the earnings beat than by evidence that the operating-margin recovery is real. The guided EBITDA step-up requires offshore migration savings to exceed onboarding costs, wage inflation and energy/logistics inputs; Q1 EBITDA conversion and utilization should be the key proof points. The normalized tax-rate reset also means reported EPS growth may lag EBITDA and free-cash-flow growth, limiting multiple expansion even if operations execute.

The market may be underweight the strategic value of IBEX’s client-retention and embedded-process footprint: enterprises deploying customer-facing AI need human escalation, compliance controls and multilingual workflow redesign, not merely a chatbot. Over 6-18 months, the company could earn a higher valuation if it demonstrates recurring AI-related revenue with stable or rising revenue per client, but the current disclosure does not establish pricing, gross-margin contribution, customer ownership, or Sierra’s economic take. The claimed results and valuation should be independently verified before treating the after-hours move as an entry signal.

Key Decisions for Investors

• Place IBEX on a post-earnings watch list rather than buy immediately; initiate a starter long only if the next report shows EBITDA margin above 13% alongside revenue growth at or above the guided range. A failure to recover margins, despite completed delivery migration, would falsify the operational-recovery thesis.
• For a 6-12 month value-oriented position, consider long IBEX only after confirming share count, cash flow after the elevated capex program, and contractual economics of the Sierra partnership. Upside requires re-rating from proven AI monetization; downside is a labor-BPO multiple if AI reduces seat volumes faster than pricing shifts to outcomes.
• Monitor CNXC and TTEC as read-through shorts/pair candidates against IBEX if enterprise AI deployments produce measurable seat displacement. Do not execute the pair without comparable AI revenue and margin disclosures; the key trigger is evidence that IBEX wins AI-led clients while peers report volume or pricing pressure.
• Treat BJ as a customer-validation watch item, not an investable AI proxy. Expansion from pilot economics into a multi-year production contract would validate enterprise willingness to pay, while discontinued use or lower-than-expected containment would weaken the broader monetization narrative.